Study in Parkinson Disease of Exercise

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Northwestern University
Study ID
NCT04284436
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
40 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Treadmill walking — BEHAVIORAL
    Treadmill walking 4 days per week for 30 minutes in the target heart rate

Study Details

This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with early stage Parkinson disease. 370 participants will be randomly assigned to 2 groups: 1)60-65% HRmax or 2)80-85% HRmax 4 times per week. The primary objective is to test whether the progression of the signs of Parkinson's disease is attenuated at 12 months in among persons who have not initiated medication for Parkinson Disease (PD) when they perform high-intensity endurance treadmill exercise.

Key Dates

Start date
Aug 30, 2021
Status verified
Apr 2026
Primary completion
Jul 31, 2027
Completion
Jul 31, 2028

Study Design

Enrollment
370 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: High Intensity Exercise
    Treadmill exercise 4x per week at 80-85% HRmax.
  • Active Comparator: Moderate Intensity Exercise
    Treadmill exercise 4x per week at 60-65% HRmax.

Primary Outcome Measure

Change in motor symptoms of Parkinson disease [ Time Frame: 12 months ]

Central Contacts

Locations (24)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35294
Candace Cromer
205-996-4034
Christopher Hurt, PhD (PRINCIPAL_INVESTIGATOR)
University of California, San FranciscoSan FranciscoCalifornia94143
Corinna Conroy
415-502-2960
Carlie Tanner (PRINCIPAL_INVESTIGATOR)
Nijee Luthra (PRINCIPAL_INVESTIGATOR)
University of Colorado, DenverAuroraColorado80204
Katherine Balfany
303.724.9101
Cory Christiansen, PhD (PRINCIPAL_INVESTIGATOR)
University of FloridaGainesvilleFlorida32611
Amanda Fessenden
352-733-2421
Demetra Christou, PhD (PRINCIPAL_INVESTIGATOR)
Emory UniversityAtlantaGeorgia30322
Joe Nocera, PhD (PRINCIPAL_INVESTIGATOR)
Morehouse School of MedicineAtlantaGeorgia30310-
Northwestern UniversityChicagoIllinois60611
Garett Griffith
7087032591
Cynthia Poon, PhD (PRINCIPAL_INVESTIGATOR)
Rush University Medical CenterChicagoIllinois60612
Wryan Mitchell
312-942-7250
Joan O'Keefe, PhD (PRINCIPAL_INVESTIGATOR)
Iowa State UniversityAmesIowa50011
Elizabeth Stegemoller, PhD
515-294-5966
Elizabeth Stegemoller, PhD (PRINCIPAL_INVESTIGATOR)
Louisiana State UniversityBaton RougeLouisiana70803
Jan Hondzinski, PhD
225-578-9144
Jan Hondzinski, PhD (PRINCIPAL_INVESTIGATOR)
Boston University (Charles River Campus)BostonMassachusetts02215
Terry Ellis, PhD (PRINCIPAL_INVESTIGATOR)
University of MichiganAnn ArborMichigan48109
Jaci Fowler
734-647-2706
Jacob Haus, PhD
734-647-2790
Jacob Haus, PhD (PRINCIPAL_INVESTIGATOR)
University of MinnesotaMinneapolisMinnesota55455
Kristin Garland
Colum MacKinnon, PhD (PRINCIPAL_INVESTIGATOR)
Washington University St. LouisSt LouisMissouri63130
Sidney Baudendistel
314-286-1641
Gammon Earhart, PhD (PRINCIPAL_INVESTIGATOR)
Columbia University Medical CenterNew YorkNew York10032
Corey Landis
212-305-1647
Ashwini Rao, EdD (PRINCIPAL_INVESTIGATOR)
University of CincinnatiCincinnatiOhio45221
Ayesha Shaik
513-558-3345
Alberto Espay, MD (PRINCIPAL_INVESTIGATOR)
Cleveland ClinicClevelandOhio44195
MacKenzie Dunlap
216-444-7474
Jay Alberts, PhD (PRINCIPAL_INVESTIGATOR)
Ohio HealthColumbusOhio43214
Marissa Mosher
614-566-1260
David Hinkle (PRINCIPAL_INVESTIGATOR)
Kent State UniversityKentOhio44240
Eileen Terrell
216-844-2328
Angela Ridgel, PhD (PRINCIPAL_INVESTIGATOR)
Oregon Health & Science UniversityPortlandOregon97239
Ashlynn Lawson
503 418-2601
Martina Mancini, PhD (PRINCIPAL_INVESTIGATOR)
University of PennsylvaniaPhiladelphiaPennsylvania19104
Victoria Vaughn
215-829-3056
Andres Diek Acost Madiedo, MD (PRINCIPAL_INVESTIGATOR)
University of PittsburghPittsburghPennsylvania15219
Adam Gaupp
412-383-0742
Alexandra Gil, PhD (PRINCIPAL_INVESTIGATOR)
UT Health San AntonioSan AntonioTexas78229
Carolyn Paiz
210-450-8830
Anjali Sivaramakrishnan, PhD (PRINCIPAL_INVESTIGATOR)
Okeanis Vaou, MD (PRINCIPAL_INVESTIGATOR)
University of UtahSalt Lake CityUtah84112
Genevieve "G" Olivier
801-587-3181
Erin Suttman
801-587-3181
Lee Dibble, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Birmingham, AL

Related Studies